Hyperuricemia, use of antituberculosis drugs, and liver injury: case report

Anti-tuberculous drug can cause idiosyncratic drug-induced liver injury (DILI). Considering the benefit risk, there will discontinuation therapy and rechallenge after symptom resolve. In addition to anti-tuberculosis drugs, liver injury can occur in patients with hyperuricemia. We report a 60-year-o...

Full description

Saved in:
Bibliographic Details
Main Authors: Vina Yuwantari, Nur Oktafiyani, Nurmelinda Hadi Ningrum, M. Hari Pristantiningtyas, Herya Putra Dharma, Muhammad Muchlis, Jainuri Erik Pratama, Fauna Herawati, Adji Prayitno Setiadi, Marisca Evalina Gondokesumo
Format: Article
Language:Indonesian
Published: Poltekkes Kemenkes Yogyakarta 2023-08-01
Series:Jurnal Teknologi Laboratorium
Subjects:
Online Access:https://teknolabjournal.com/index.php/Jtl/article/view/445
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560750453161984
author Vina Yuwantari
Nur Oktafiyani
Nurmelinda Hadi Ningrum
M. Hari Pristantiningtyas
Herya Putra Dharma
Muhammad Muchlis
Jainuri Erik Pratama
Fauna Herawati
Adji Prayitno Setiadi
Marisca Evalina Gondokesumo
author_facet Vina Yuwantari
Nur Oktafiyani
Nurmelinda Hadi Ningrum
M. Hari Pristantiningtyas
Herya Putra Dharma
Muhammad Muchlis
Jainuri Erik Pratama
Fauna Herawati
Adji Prayitno Setiadi
Marisca Evalina Gondokesumo
author_sort Vina Yuwantari
collection DOAJ
description Anti-tuberculous drug can cause idiosyncratic drug-induced liver injury (DILI). Considering the benefit risk, there will discontinuation therapy and rechallenge after symptom resolve. In addition to anti-tuberculosis drugs, liver injury can occur in patients with hyperuricemia. We report a 60-year-old male patient who had just used the initiation phase of OAT for 20 days experiencing hepatotoxic side effects characterized by complaints of nausea and vomiting for one week. Liver function examination results were normal with AST 23 u/L and ALT 9 u/L. OAT administration was temporarily stopped and started gradually with 150 mg rifampicin, 150 mg isoniazid and 500 mg ethambutol. The second day after using OAT again, given the full dose of 300 mg rifampicin, 300 mg isoniazid and 1000 mg ethambutol. The patient's condition improved after this modification of therapy so that therapy with three anti-TB drugs was continued until he was discharged from the hospital.
format Article
id doaj-art-01788e89997542b3a54bfb5fe4c91cae
institution Kabale University
issn 2338-5634
2580-0191
language Indonesian
publishDate 2023-08-01
publisher Poltekkes Kemenkes Yogyakarta
record_format Article
series Jurnal Teknologi Laboratorium
spelling doaj-art-01788e89997542b3a54bfb5fe4c91cae2025-01-03T15:40:13ZindPoltekkes Kemenkes YogyakartaJurnal Teknologi Laboratorium2338-56342580-01912023-08-01121404510.29238/teknolabjournal.v12i1.445397Hyperuricemia, use of antituberculosis drugs, and liver injury: case reportVina Yuwantari0Nur Oktafiyani1Nurmelinda Hadi Ningrum2M. Hari Pristantiningtyas3Herya Putra Dharma4Muhammad Muchlis5Jainuri Erik Pratama6Fauna Herawati7Adji Prayitno Setiadi8Marisca Evalina Gondokesumo9University of SurabayaMardi Waluyo Regional Public HospitalMardi Waluyo Regional Public HospitalMardi Waluyo Regional Public HospitalMardi Waluyo Regional Public HospitalMardi Waluyo Regional Public HospitalDr. Kariadi Central General HospitalUniversity of SurabayaUniversity of SurabayaUniversitas SurabayaAnti-tuberculous drug can cause idiosyncratic drug-induced liver injury (DILI). Considering the benefit risk, there will discontinuation therapy and rechallenge after symptom resolve. In addition to anti-tuberculosis drugs, liver injury can occur in patients with hyperuricemia. We report a 60-year-old male patient who had just used the initiation phase of OAT for 20 days experiencing hepatotoxic side effects characterized by complaints of nausea and vomiting for one week. Liver function examination results were normal with AST 23 u/L and ALT 9 u/L. OAT administration was temporarily stopped and started gradually with 150 mg rifampicin, 150 mg isoniazid and 500 mg ethambutol. The second day after using OAT again, given the full dose of 300 mg rifampicin, 300 mg isoniazid and 1000 mg ethambutol. The patient's condition improved after this modification of therapy so that therapy with three anti-TB drugs was continued until he was discharged from the hospital.https://teknolabjournal.com/index.php/Jtl/article/view/445adverse effectantituberculosisdrug induced liver injury
spellingShingle Vina Yuwantari
Nur Oktafiyani
Nurmelinda Hadi Ningrum
M. Hari Pristantiningtyas
Herya Putra Dharma
Muhammad Muchlis
Jainuri Erik Pratama
Fauna Herawati
Adji Prayitno Setiadi
Marisca Evalina Gondokesumo
Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
Jurnal Teknologi Laboratorium
adverse effect
antituberculosis
drug induced liver injury
title Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
title_full Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
title_fullStr Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
title_full_unstemmed Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
title_short Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
title_sort hyperuricemia use of antituberculosis drugs and liver injury case report
topic adverse effect
antituberculosis
drug induced liver injury
url https://teknolabjournal.com/index.php/Jtl/article/view/445
work_keys_str_mv AT vinayuwantari hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT nuroktafiyani hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT nurmelindahadiningrum hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT mharipristantiningtyas hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT heryaputradharma hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT muhammadmuchlis hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT jainurierikpratama hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT faunaherawati hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT adjiprayitnosetiadi hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport
AT mariscaevalinagondokesumo hyperuricemiauseofantituberculosisdrugsandliverinjurycasereport